Think Bioscience Secures $55 Million in Oversubscribed Series A Funding Think Bioscience raises $55 million in an oversubscribed Series A round, focusing on innovative drug discoveries for urgent medical needs.

Think Bioscience Secures $55 Million in Oversubscribed Series A Funding #United_States #biotechnology #Boulder #Series_A #Think_Bioscience